Dr. Charles Peterfy, Chief Scientific Officer at Synarc in San Francisco, CA will give the featured address entitled “Successful Multi-Site MRI in Rheumatoid Arthritis Clinical Trials: Overcoming Single-Site Mindedness.†at GTCbio’s 4th annual Imaging in Preclinical & Clinical Drug Development Conference on March 16-17, 2009 in San Francisco, CA.
Dr. Peterfy’s presentation will examine the unique challenges to successful multi-site magnetic resonance imaging (MRI) in clinical trials of Rheumatoid Arthritis (RA). He will specify the critical image-quality drivers of accurate readings, which elements of the MRI protocol are most important to these image attributes, and techniques that can ensure good images.
Dr. Peterfy is co-founder and Chief Scientific Officer of Synarc, an international organization providing centralized medical imaging and molecular marker services and clinical-research facilities to the pharmaceutical, biotechnology and medical devices industries. He is a board-certified radiologist with 20 years experience in clinical radiology and fellowship training in musculoskeletal imaging from the University of California San Francisco.
4th Annual Imaging in Clinical & Pre-clinical Drug Development Conference will give attendees a comprehensive look at the latest developments in preclinical and clinical imaging including the advancements in PET Probe and In Vivo MRI; it will help attendees alleviate the biggest issues such as cost and the understanding of FDA regulations. For more information visit http://gtcbio.com/conferenceDetails.aspx?id=146.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO 434 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 256-6460 email: [email protected]
